Steris Plc (NYSE:STE) declared a quarterly dividend on Wednesday, November 1st, Zacks reports. Stockholders of record on Wednesday, November 22nd will be given a dividend of 0.31 per share by the medical equipment provider on Wednesday, December 20th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Tuesday, November 21st.
Steris Plc has increased its dividend payment by an average of 9.8% annually over the last three years and has increased its dividend annually for the last 7 consecutive years. Steris Plc has a dividend payout ratio of 30.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Steris Plc to earn $4.54 per share next year, which means the company should continue to be able to cover its $1.24 annual dividend with an expected future payout ratio of 27.3%.
Steris Plc (STE) opened at $87.85 on Monday. Steris Plc has a 1 year low of $64.37 and a 1 year high of $93.39. The stock has a market cap of $7,471.85, a price-to-earnings ratio of 22.64 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.80 and a quick ratio of 2.18.
In other Steris Plc news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $90.50, for a total transaction of $905,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard Martin Steeves sold 156,072 shares of the company’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $87.13, for a total transaction of $13,598,553.36. Following the sale, the director now owns 9,362 shares of the company’s stock, valued at $815,711.06. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 192,722 shares of company stock valued at $16,913,753. Company insiders own 2.55% of the company’s stock.
Several brokerages recently issued reports on STE. TD Securities upped their target price on shares of Steris Plc from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research lowered shares of Steris Plc from a “buy” rating to a “sell” rating in a research report on Monday, November 6th. KeyCorp reiterated an “overweight” rating and issued a $101.00 target price (up from $91.00) on shares of Steris Plc in a research report on Thursday, November 2nd. Raymond James Financial, Inc. upped their target price on shares of Steris Plc from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Finally, BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. Steris Plc currently has an average rating of “Hold” and a consensus price target of $77.80.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.